The global nucleic acid testing market is poised for significant growth, with market size expected to reach USD 3.7 billion in 2023. According to recent forecasts, overall sales of nucleic acid testing are projected to grow at a compound annual growth rate (CAGR) of 6.8%, reaching a valuation of USD 7.2 billion by the end of 2033.
The growth of the nucleic acid testing market is primarily driven by increasing investment from both government and private sectors in the development of novel biotechnological diagnostic techniques. The demand for technologically advanced diagnostic measures is also on the rise, further bolstering market expansion.
Despite these positive trends, certain challenges persist within the nucleic acid testing market. Some testing approaches are noted for being time-consuming, expensive, technically challenging, and not user-friendly, which have contributed to a decline in basis points (BPS) values. Additionally, the need for integrated systems with digitally improved data point displays for diagnostic patterns arises due to the inability of multiple devices to simultaneously consider disease detection time and test sensitivity.
Portability remains a significant limitation for current nucleic acid testing devices. Although these devices offer quick sample-to-result diagnostics, their lack of portability can render them unaffordable for many users, particularly in resource-limited settings. These limitations are expected to impact overall demand within the nucleic acid testing market over the projected period.
Technological advancements are playing a crucial role in the development of new nucleic acid analysis solutions. Innovations such as CRISPR gene editing and Next-Generation Sequencing (NGS) are facilitating more accurate and efficient gene editing and genomic analysis. These technologies are improving the accuracy and speed of nucleic acid testing, enabling quicker and more effective diagnosis of diseases and genetic disorders.
The growing demand for personalized medicine is another significant driver of market growth. Personalized medicine leverages a patient’s genetic information to customize medical treatment, and nucleic acid testing is a critical tool in this approach. By providing insights into a patient’s genetic makeup, nucleic acid testing helps doctors develop tailored treatment plans. This approach has seen particular success in the field of oncology, where personalized treatment options are becoming increasingly prevalent.
As the nucleic acid testing market continues to evolve, the integration of advanced technologies and the rise of personalized medicine are set to transform diagnostic and treatment paradigms, offering new opportunities for growth and innovation.
Key Takeaways:
- By 2033, the Indian nucleic acid amplification testing market is estimated to reach USD 341.3 million.
- By 2033, it is estimated that the Chinese market for nucleic acid testing to reach USD 659.1 million.
- The Japanese market for nucleic acid testing is expected to generate USD 525.6 million in revenue by 2033.
- During the projection year, the US market may grow at a CAGR of 6.8%.
- The kits product type is expected to increase at a CAGR of 6.4% during the projected period.
- The CAGR for the UK market might be 6.7% between 2023 and 2033.
- The Japanese market is expected to increase at a CAGR of 6.3% over the forecast period.
- The Indian nucleic acid testing market is expected to develop at a CAGR of 10.6% between 2023 and 2033.
- The Chinese market for nucleic acid testing is expected to grow at a CAGR of 7% between 2023 and 2033.
- The UK market for nucleic acid testing is estimated to produce USD 267.5 Million in sales by 2033.
- The US market is estimated to reach USD 2.0 Billion by 2033.
- Infectious Diseases may grow at a CAGR of 7.1% in the indication category during the predicted year.
Nucleic Acid Testing Market Competitive Landscape:
Due to strategic initiatives taken by emerging and significant companies, the nucleic acid testing market is extremely competitive. Several new types of nucleic acid testing have been introduced in recent years.
Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Illumina, Inc., Siemens AG, Hologic Inc., bioMérieux SA, Novartis AG, F. Hoffmann-La Roche Ltd., Sequenom, Tecan Trading AG., and others are among the main players in the global market.
Recent Development:
- September 2022, My lab Discovery Solutions debuted their Patho Detect HPV Identification PCR Test for the detection of human papillomavirus (HPV) in high-risk patients.
- Abingdon Health announced a new version of the successful NALFIA fast test in January 2019 for the detection of DIG/Biotin and/or FITC (Or FAM)/biotin-labeled analytes.
- In September 2018, researchers at the National University of Singapore created a portable platform for a point-of-care nucleic acid test that can be used to diagnose a variety of diseases. “enVision” is the name of the device (enzyme-assisted nanocomplexes for visual identification of nucleic acids)
Get Comprehensive Market Data: Download the Complete Nucleic Acid Testing Market Report
Key Segments:
By Product Type:
- Nucleic Acid Test Kits
- Transcription-Mediated Amplification (TMA)
- Polymerase Chain Reaction (PCR)
- Ligase Chain Reaction (LCR)
- Whole Genome Sequencing
- Consumables
By Indication:
- Infectious diseases
- Cancer
- Forensic Testing
- Others
By End-user:
- Hospitals
- Pathology laboratories
- Research Institutes
- Clinics
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APECJ
- China
- Japan
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube